Article
Twitcher mice with only a single active galactosylceramide synthase gene exhibit clearly detectable but therapeutically minor phenotypic improvements.
Journal of neuroscience research - 15 Jan 2000
Ezoe T, Vanier M T, Oya Y, Popko B, Tohyama J, Matsuda J, Suzuki K, Suzuki K
Abstract excerpt
Cross-breeding of mouse mutants, each defective in either synthesis (CGT knockout) or degradation (twitcher) of galactosylceramide, generates hybrids with a genotype of galc -/-, cgt +/-, in addition to doubly deficient mice. They are ideally suited to test the potential usefulness of limiting synthesis of the substrate as a treatment of genetic disorders due to degradative enzyme defects. The rate of accretion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
